The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

Researchers at the University of Toronto and University of Calgary have developed an innovative approach that uses artificial ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

Modern AI technology is data-hungry. In many areas, data is scarce. For example, in our work in early oncology clinical trials, we only have data on about 20 patients, so we tend to use theory-based ...

AI assistance was seen to speed screening and recruitment for clinical trials, potentially helping patients access novel therapies faster.

Patients expressed concern that overreliance on artificial intelligence (AI) could lead to clinicians losing their skills, ...

Molecular Devices' CellXpress AI streamlines cell culture processes, reducing human error and improving efficiency in drug ...

Insilico Medicine, an AI drug discovery company based in Hong Kong and Boston, has joined the unicorn club after raising $110 million in a funding round led by Hong Kong-headquartered asset ...

Breast cancer patients who underwent postmastectomy breast reconstruction had lower sexual well-being scores compared with ...

Dermatoscope imaging processed with AI has been in use in the UK for 4 years with accuracy shown to be at least equal to ...

Insilico and rivals like Atomwise Inc. and BenevolentAI aim to use AI to improve drug discovery, historically a time-consuming and costly process. It’s one of the fields AI optimists have been ...